Periodic Reporting for period 1 - DifMATRIX (Ground breaking 3D cell culture platform to eliminate animal testing in pharmaceuticals)

85% of early clinical trials currently fail despite successful preclinical in vitro testing. In the case of clinical cancer trials, it is less than 8%. The main reason for such low success rates is that currently used in vitro 2D cell cultures do not mimic living body...